Evaluation of QbTest on a smartphone- A Clinical Investigation

Evaluation of QbTest on a smartphone- A Clinical Investigation - QbMT - A CLINICAL INVESTIGATION

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON53743

Enrollment

250

Registered

2022-11-25

Start date

2022-10-01

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD Attention-Deficit/Hyperactivity Disorder

Interventions

None listed

Eligibility

Age

2 Years to 64 Years

Inclusion criteria

Inclusion criteria: •Provide written informed consent (including parent/legally authorized representative (LAR) consent when this is required for individuals under 18 years old and assent as is required based on the age of participant) for QbMT; •Aged > 6 years and

Exclusion criteria

Exclusion criteria: •intellectual disability designated by IQ

Design outcomes

Primary

Measure	Time frame
The QbMT feasibility examination will involve as a primary objective, the examination of the data flow in the use of QbMT to identify potential errors or technical issues that may be associated with the data collection and QbTest parameter calculation. We will further examine the validity of QbMT in individuals diagnosed with ADHD. All the available QbTest measures of activity, impulsivity, and attention will be included as measures of interest in this study. These are described in the Measures section of the protocol.	—

Measure

Time frame

The QbMT feasibility examination will involve as a primary objective, the examination of the data flow in the use of QbMT to identify potential errors or technical issues that may be associated with the data collection and QbTest parameter calculation. We will further examine the validity of QbMT in individuals diagnosed with ADHD. All the available QbTest measures of activity, impulsivity, and attention will be included as measures of interest in this study. These are described in the *Measures* section of the protocol.

—

Secondary

Measure	Time frame
The secondary objective of the QbMT study is to explore additional eye-movement variables and parameters that can be calculated from a mobile camera device and the mobile use of QbTest such as indices of activity, attention, and impulsivity, and compare this with individuals with and without ADHD.	—

Countries

Netherlands

Outcome results